Monjuvi, illustration of pre-filled syringe form (not a photo of the actual pack)

Illustrative image.

Monjuvi

Tafasitamab

Prescription required

$1460.00

200mg · 1 syringes

BrandBranded medicine· By Incyte

Choose a pack

  • Selected pack

Packs in this delivery

1

Test mode: no payment is taken. View cart

Prescription required

Upload your prescription after ordering, or send it to our pharmacy team. We dispense only against a valid prescription.

About Monjuvi

Overview

Monjuvi (tafasitamab-cxix) is a monoclonal antibody used with lenalidomide to treat adults with diffuse large B-cell lymphoma (DLBCL), not otherwise specified, that has returned or has not responded to treatment. This includes DLBCL arising from low-grade lymphoma, in people who are not eligible for an autologous stem cell transplant. It binds to a protein called CD19 on B cells, including cancerous B cells, helping the immune system destroy them and triggering cell death. This use has FDA accelerated approval based on treatment response rates; continued approval may depend on further trials confirming clinical benefit.

What it treats

• Used with lenalidomide to treat adults with diffuse large B-cell lymphoma (DLBCL), not otherwise specified, that has returned or has not responded to treatment, including DLBCL arising from low-grade lymphoma, when they are not eligible for an autologous stem cell transplant (using their own stem cells).

Safety information

Side effects

Common side effects include low white blood cell counts, tiredness, anemia (low red blood cell counts), diarrhea, low platelet counts, cough, fever, swelling in the limbs, respiratory tract infections and decreased appetite. Serious side effects that warrant contacting a doctor include infusion-related reactions, reduced blood cell production and bacterial, fungal or viral infections. Infections can occur during or after treatment. Blood counts need monitoring, and treatment may need to be interrupted or stopped depending on severity. Tell the healthcare team immediately about any reaction during an infusion. Monjuvi may harm an unborn baby. Use effective contraception if you could become pregnant, and contact your doctor if you become pregnant during treatment.

When to call your doctor

- Seek medical attention immediately if you develop a fever or a cough that may signal an infection. Infections can occur during or after Monjuvi treatment.

If symptoms are severe or getting worse quickly, seek emergency care rather than waiting.

Using Monjuvi

Dosing

Dosing is set by your prescriber. Each health care professional may prescribe medication differently according to a patient's medical history and condition, so follow the directions on your prescription label and speak to your doctor or pharmacist before changing anything.

Storage

Store in the original carton to protect it from light. Check the pack for whether it must be refrigerated before first use. Keep all medicines out of the sight and reach of children.

Clinical information on this page is summarised from the US FDA label MONJUVI (TAFASITAMAB-CXIX) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [INCYTE CORPORATION] (DailyMed, retrieved 19 September 2026).

Reviews

No reviews yet. Mail Order Drugs opened recently, and we publish reviews only from verified customers of this site, so this space stays empty until real ones arrive.

  • Every prescription order is checked by a licensed pharmacist before dispensing.
  • Payment pages are encrypted and card details never reach our servers.
  • We ship internationally, with cold-chain packing where a medicine needs it.

Related medicines